Search results

Order by most recent / most popular / relevance

Results: 1-10 of 278

In Uship Federal Circuit finds prosecution history disclaimer in arguments against restriction requirement

Foley & Lardner LLP
-
USA
-
May 23 2013

In Uship Intellectual Properties, LLC v. United States, the Federal Circuit upheld the claim construction applied by the Court of Federal Claims when

USPTO launches new After Final Consideration Pilot Program to reduce requests for continued examination (RCEs)

Foley & Lardner LLP
-
USA
-
May 20 2013

In a Federal Register Notice published on May 17, 2013, the USPTO announced After Final Consideration Pilot Program 2.0 (AFCP 2.0) as part of its

Supreme Court finds for Monsanto in seed harvesting case

Foley & Lardner LLP
-
USA
-
May 16 2013

In Bowman v. Monsanto Co., the Supreme Court held that the doctrine of patent exhaustion does not give a farmer who has bought patented seeds the

Federal Circuit issues fractured affirmance in CLS Bank v. Alice Corporation

Foley & Lardner LLP
-
USA
-
May 12 2013

In a fractured en banc decision, the Federal Circuit affirmed the district court's holding that the claims at issue in CLS Bank v. Alice Corporation

USPTO reshuffles the RCE deck

Foley & Lardner LLP
-
USA
-
May 9 2013

The USPTO still is considering information gathered during its RCE Outreach program, but it has made some internal changes that should lead to more

Federal Circuit upholds one claim covering Combigan

Foley & Lardner LLP
-
USA
-
May 7 2013

In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit reversed the district court in part, finding that Allergan's composition claims and most of

Federal Circuit holds that patent indefiniteness requires insoluble ambiguousness

Foley & Lardner LLP
-
USA
-
May 2 2013

In Biosig Instruments, Inc. v. Nautilus Inc., the Federal Circuit reversed the district court's finding that the claims at issue were invalid as

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Federal Circuit finds Yaz patent obvious

Foley & Lardner LLP
-
USA
-
April 25 2013

In Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court and held that Bayer's

Challenging the enabling quality of Prior Art

Foley & Lardner LLP
-
USA
-
April 18 2013

In In re Morsa, the Federal Circuit reversed an anticipation rejection where the applicant had challenged the enabling quality of the cited prior art

next >

Search results

In Uship Federal Circuit finds prosecution history disclaimer in arguments against restriction requirement

USPTO launches new After Final Consideration Pilot Program to reduce requests for continued examination (RCEs)

Supreme Court finds for Monsanto in seed harvesting case

Federal Circuit issues fractured affirmance in CLS Bank v. Alice Corporation

USPTO reshuffles the RCE deck

Federal Circuit upholds one claim covering Combigan

Federal Circuit holds that patent indefiniteness requires insoluble ambiguousness

Dispelling the Myriad gene patent harmonization myth

Federal Circuit finds Yaz patent obvious

Challenging the enabling quality of Prior Art

Current Search

Suggested Facets

Author

Jurisdiction

Workarea